Male Infertility
Conditions
Interventions
Test Group:Take Zangdi Babao Tablets, 2 tablets each time, 3 times a day, for 12 consecutive weeks.
Control Group:Take a placebo consistent with Zangdi Babao Tablets in terms of appearance, specifications and usage, for 12 consecutive weeks.
Sponsors
Hospital for Reproductive Medicine Affiliated to Shandong University
Eligibility
Sex/Gender
Male
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Male, aged 20-45 years; 2. Meeting the diagnosis of male infertility: failure to conceive after 1 year of unprotected intercourse, with normal examination results of the female partner; 3. Baseline sperm progressive motility rate < 32%; 4. Voluntarily participating in the study and signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Congenital malformation of the reproductive system or severe acquired injury; 2. Abnormal liver or kidney function (ALT/AST > 1.5 times the upper limit of normal); 3. Use of drugs to improve sperm quality in the past 3 months; 4. Allergy to the ingredients of Zangdi Babao Tablets; 5. Complicated with severe underlying diseases such as malignant tumors and mental illnesses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sperm progressive motility rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum testosterone level,;sperm deformity rate,;IIEF-15 score; | — |
Countries
China
Contacts
Public ContactJingmei Hu
Hospital for Reproductive Medicine Affiliated to Shandong University
Outcome results
None listed